Clinical Trials
25 trialsA Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer
Anhui Provincial Cancer Hospital
ICT-HCC
Nanjing Tianyinshan Hospital
Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer
China Medical University, China
Apatinib for Resectable Colorectal Cancer
Nanchong Central Hospital
Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
Beijing Sanbo Brain Hospital
TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma
Zhongda Hospital
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
Qilu Hospital of Shandong University
BABST-C
Shenzhen People's Hospital
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Xiangya Hospital of Central South University
Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Camrelizumab Combined With Apatinib Mesylate
Henan Cancer Hospital
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Peking University People's Hospital
Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd.
A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC
Beijing Chest Hospital
AIAC
Peking University People's Hospital
Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer
Qianfoshan Hospital
HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer
Wuhan University
PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer
Fujian Cancer Hospital
ARCAP
Sichuan Provincial People's Hospital
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
Tianjin Medical University Cancer Institute and Hospital
SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery
Shanghai Zhongshan Hospital
HCC
Tianjin Medical University Cancer Institute and Hospital
Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer
Guangdong Provincial People's Hospital
Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Jiangsu Cancer Institute & Hospital
Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
Third Military Medical University